Skip to main content
Irwin Naturals Inc. logo

Irwin Naturals Inc. — Investor Relations & Filings

Ticker · IWIN ISIN · CA46414Q1054 LEI · 9845003CF0B7JE8FAX54 CSE Manufacturing
Open in API
Filings indexed 255 across all filing types
Latest filing 2022-08-30 Regulatory Filings
Country CA Canada
Listing CSE IWIN

About Irwin Naturals Inc.

https://irwinnaturals.com/

Irwin Naturals Inc. is a nutraceutical company focused on developing and distributing premium health supplements and vitamins. The company specializes in soft-gel based herbal formulas, prioritizing superior potency, bioavailability, and absorption. Its product portfolio includes targeted formulas for general wellness, sleep, cognitive function, detoxification, and weight management, alongside a range of CBD and THC products. A core unique selling proposition is the utilization of an all-liquid soft-gel delivery system combined with the signature BioPerine Complex, which is designed to enhance nutrient uptake. Irwin Naturals distributes its extensive line of supplements through mass-market and health food chain retailers across North America.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings
2022-08-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2022-08-29 English
Interim MD&A - English.pdf
Regulatory Filings
2022-08-29 English
Interim financial statements/report – English.pdf
Regulatory Filings
2022-08-29 English
Material change report - English.pdf
Regulatory Filings Classification · 95% confidence The document is titled 'Form 51-102F3 MATERIAL CHANGE REPORT' and details a material change event involving an asset purchase agreement and acquisition completed by the company. It includes specifics about the transaction, issuance of shares as consideration, and forward-looking statements. The document is a formal regulatory filing reporting a material change rather than a full financial report or earnings release. It does not contain financial statements or detailed financial analysis but rather announces a significant corporate event. This fits the definition of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2022-08-23 English
News release - English.pdf
Capital/Financing Update Classification · 95% confidence The document is a press release announcing the acquisition of a Vermont ketamine treatment clinic by Irwin Naturals Emergence. It details the transaction terms, company background, and forward-looking statements. There are no financial statements, regulatory certifications, or detailed financial performance data included. The document focuses on a corporate acquisition and expansion update rather than a formal merger filing or detailed financial report. It is not a merger proxy statement or tender offer filing (MA or TAR), nor is it a full annual or interim report. The content fits best as a Capital/Financing Update (CAP) because it announces a financing-related transaction (acquisition) and related share issuance as consideration. The document length and detail support this classification with high confidence.
2022-08-15 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.